IGC Pharma Inc [AMEX: IGC] closed the trading session at $0.37 on 2025-07-09. The day’s price range saw the stock hit a low of $0.317, while the highest price level was $0.375.
The stocks have a year to date performance of -9.64 percent and weekly performance of 20.59 percent. The stock has been moved at 2.52 percent over the last six months. The stock has performed 19.37 percent around the most recent 30 days and changed 26.29 percent over the most recent 3-months.
If compared to the average trading volume of 227.23K shares, IGC reached to a volume of 20576782 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about IGC Pharma Inc [IGC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IGC shares is $3.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IGC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 4.68, with the Price to Cash per share for the same quarter was set at 0.00.
IGC stock trade performance evaluation
IGC Pharma Inc [IGC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.59. With this latest performance, IGC shares gained by 19.37% in over the last four-week period, additionally plugging by 2.52% over the last 6 months – not to mention a rise of 8.93% in the past year of trading.
IGC Pharma Inc [IGC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and IGC Pharma Inc [IGC] shares currently have an operating margin of -585.84% and a Gross Margin at 4.33%. IGC Pharma Inc’s Net Margin is presently recorded at -560.27%.
Return on Equity for this stock declined to -76.37%, with Return on Assets sitting at -76.37%.
IGC Pharma Inc [IGC]: Institutional Ownership
There are presently around $19.89%, or 21.89% of IGC stock, in the hands of institutional investors. The top three institutional holders of IGC stocks are: BLACKROCK INC. with ownership of 0.7 million shares, which is approximately 1.1961%. VANGUARD GROUP INC, holding 0.65 million shares of the stock with an approximate value of $$0.28 million in IGC stocks shares; and VANGUARD GROUP INC, currently with $$0.19 million in IGC stock with ownership which is approximately 0.7305%.
